Mark Dybul
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 27
- HIV/AIDS drug development and treatment 8
- Epidemiology 17
- HIV, Drug Use, Sexual Risk 12
- Co-authors
- Edward J. Mills (4 shared papers)Josephine Birungi (4 shared papers)Peter Piot (8 shared papers)Timothy B. Hallett (5 shared papers)Annette Oxenius (1 shared paper)Michael R. Betts (1 shared paper)Mark Connors (1 shared paper)Steven M. Wolinsky (1 shared paper)
- Journals
- The Lancet (8 papers)AIDS (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)PLoS ONE (3 papers)Journal of the International AIDS Society (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Dybul
35 papers receiving 3.6k citations
Mark Dybul's Hit Papers
Peers
Comparison fields: 5 of 131
- Virology 1.9k
- Infectious Diseases 2.5k
- Emergency Medicine 398
- Epidemiology 1.4k
- Immunology 820
Countries citing papers authored by Mark Dybul
This map shows the geographic impact of Mark Dybul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dybul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dybul more than expected).
Fields of papers citing papers by Mark Dybul
This network shows the impact of papers produced by Mark Dybul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dybul. The network helps show where Mark Dybul may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dybul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HIV preferentially infects HIV-specific CD4+ T cells Hit paper breakdown → | 2002 | 982 |
| 2 | 2002 | 368 | |
| 3 | 1999 | 338 | |
| 4 | 2011 | 312 | |
| 5 | 2012 | 195 | |
| 6 | 2014 | 170 | |
| 7 | 2002 | 154 | |
| 8 | 2012 | 145 | |
| 9 | 2012 | 127 | |
| 10 | 2012 | 112 | |
| 11 | 2001 | 111 | |
| 12 | 2014 | 91 | |
| 13 | 2013 | 81 | |
| 14 | 2012 | 80 | |
| 15 | 2003 | 62 | |
| 16 | 2016 | 60 | |
| 17 | 2010 | 49 | |
| 18 | 2012 | 49 | |
| 19 | 2012 | 45 | |
| 20 | 2010 | 41 |
About Mark Dybul
Mark Dybul is a scholar working on Infectious Diseases, Epidemiology, General Health Professions, Virology and Pediatrics, Perinatology and Child Health, having authored 35 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (27 papers), HIV, Drug Use, Sexual Risk (12 papers), HIV Research and Treatment (10 papers), Adolescent Sexual and Reproductive Health (10 papers), HIV/AIDS drug development and treatment (8 papers), Sex work and related issues (5 papers), Global Maternal and Child Health (5 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Virology (1.9k citations), Infectious Diseases (2.5k citations), Emergency Medicine (398 citations), Epidemiology (1.4k citations) and Immunology (820 citations). Mark Dybul has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Edward J. Mills, Josephine Birungi, Peter Piot, Timothy B. Hallett, Annette Oxenius, Michael R. Betts, Mark Connors, Steven M. Wolinsky, Zvi Grossman and Yukari Okamoto. Their work appears in journals such as The Lancet, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, PLoS ONE and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.